A further report on the effect of distigmine bromide (Ubretid) on the neurogenic bladder.
D002219:Carbamates / Q000008:administration & dosage / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D010264:Paraplegia / Q000150:complications; D011726:Pyridinium Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D011782:Quadriplegia / Q000150:complications; D011859:Radiography; D001748:Urinary Bladder Neck Obstruction / Q000150:complications; D001750:Urinary Bladder, Neurogenic / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D014554:Urination / Q000187:drug effects
D002219:Carbamates; D002800:Cholinesterase Inhibitors; D011726:Pyridinium Compounds